Clinical Focus
Previous Articles Next Articles
Online:
Published:
Contact:
Abstract: Objective To investigate the anticoagulant effect of different initial dose of argatroban in patients with hemorrhage tendency undergoing continuous renal placement therapy (CRRT).Methods One hundred and fortyone patients of hemorrhage tendency undergoing CRRT were divided into four groups according to the different initial dose: 0 μg/kg group, 20 μg/kg group, 30 μg/kg group and 40 μg/kg group, each group maintenance was 24 μg/(kg·h). The activated partial thromboplastin time(APTT) was observed before, during and after treatment. The coagulation hemofilter and blood pipeline were observed during and after treatment. Results The change of APTT in 30 μg/kg group kept relatively stable and APTT maintained between 1.5 and 2.5 times than before argatroban, venous pressure was stable and anticoagulant was effective. Conclusion The initial dose in 30 μg/kg group with CRRT is successful withnot coagulation and bleeding trends.
Key words: renal , dialysis; , anticoagulants; , argatroban anhydrous
Li Yingping, Ma Zhigang, Huang Wenhui, Huang Junyue, Xue Rong, Lu Shouyan. Initial dose of argatroban in patients with hemorrhage tendency undergoing continuous renal replacement therapy[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2017.11.011.
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2017.11.011
https://huicui.hebmu.edu.cn/EN/Y2017/V32/I11/961